Skip to main content
. 2016 Apr 25;49(1):89–98. doi: 10.3892/ijo.2016.3496

Figure 1.

Figure 1

The expression of CD13 before and after treatment with anticancer drugs, with/without ubenimex. (A) The expression of CD13 was 3.5±0.5% in HuH7 cells and 3.9±0.4% in PLC/PRF/5 cells. (B) The expression of CD13 increased after 72 h of exposure to 5-FU, CDDP, DXR and SOR in HuH7 cells and PLC/PRF/5 cells; (P<0.05). (C) When ubenimex (Ube) was combined with each anticancer drug, the expression of CD13 decreased compared to the anticancer drug alone in HuH7 cells and PLC/PRF/5 cells (P<0.05).